| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | |||||||||
Net income | |||||||||
30,287 | 25,038 | 11,838 | 18,943 | 11,943 | 12,312 | 9,238 | 8,069 | 8,204 | 7,497 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
Depreciation and amortization | |||||||||
431 | 380 | 320 | 269 | 251 | 348 | 337 | 358 | 366 | - |
Depreciation and amortization | |||||||||
- | - | - | - | - | - | - | - | - | 348 |
Provision for loan losses | |||||||||
2,700 | 1,800 | 2,500 | 1,462 | 3,040 | 3,250 | 2,700 | 7,300 | 10,450 | 9,001 |
Increase in value of bank-owned life insurance | |||||||||
601 | 613 | 652 | 722 | 357 | 359 | 363 | 202 | 179 | 178 |
Bank owned life insurance additional purchase | |||||||||
- | - | - | 0 | 12,000 | 0 | - | - | - | - |
Supplemental executive retirement plan expense | |||||||||
- | - | - | - | - | - | 33 | 135 | 477 | - |
Gain on sale of SBA loans | |||||||||
116 | 378 | 477 | 1,819 | 4,147 | 5,040 | 2,225 | 3,582 | 4,439 | 1,789 |
SBA loans originated for sale | |||||||||
- | - | - | 15,080 | 38,244 | 34,538 | 29,471 | 32,199 | 27,171 | 28,392 |
SBA loans originated for sale | |||||||||
940 | 4,696 | 5,807 | - | - | - | - | - | - | - |
Proceeds from sale of SBA related assets | |||||||||
- | - | - | 50,348 | 0 | - | - | - | - | - |
Proceeds from sale of SBA loans originated for sale | |||||||||
1,285 | 6,196 | 4,743 | 2,638 | 0 | 48,714 | 20,122 | 35,595 | 30,230 | 31,386 |
Proceeds from sale of SBA loans originated for sale | |||||||||
- | - | - | 16,901 | 42,684 | - | - | - | - | - |
Net loss on sale of OREO and valuation adjustments | |||||||||
-246 | -690 | -1,422 | -1,830 | -2,019 | -596 | -662 | -999 | 557 | - |
Gain on sale of SBA related assets | |||||||||
- | - | - | 7,611 | 0 | 178 | 251 | - | - | - |
Contribution of OREO property | |||||||||
- | - | - | - | - | 22 | 0 | -139 | - | - |
Provision for OREO | |||||||||
- | - | - | - | - | 1,493 | 2,417 | - | - | - |
Provision for OREO | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Net loss on sale of OREO and valuation adjustments | |||||||||
- | - | - | - | - | - | - | - | - | -1,272 |
Other than temporary decline in value of investments | |||||||||
- | - | - | - | - | - | - | - | - | -124 |
Net accretion of purchase premiums and discounts on securities | |||||||||
-38 | -45 | -65 | 44 | 623 | -9 | 135 | -3 | 68 | 194 |
Purchase of treasury stock | |||||||||
- | - | - | 4 | 831 | 0 | - | - | - | - |
Stock based compensation | |||||||||
176 | 109 | 72 | 66 | 0 | - | - | - | - | 508 |
Deferred income tax | |||||||||
163 | -58 | -4,143 | -305 | 190 | -1,789 | 126 | 1,343 | - | - |
Contribution of Other Real Estate Owned Property | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Other than temporary decline in value of investments | |||||||||
- | - | - | - | - | - | 955 | 0 | 129 | - |
Deferred income tax benefit | |||||||||
- | - | - | - | - | - | - | - | -1,801 | -1,726 |
Net changes in: | |||||||||
Decrease in accrued interest receivable and other assets | |||||||||
181 | 1,657 | - | - | - | - | - | - | - | - |
Decrease in accrued interest receivable and other assets | |||||||||
- | - | 59 | -594 | 1,008 | 2,930 | -334 | -851 | -1,180 | -995 |
Increase (decrease) in accrued interest payable and other accrued liabilities | |||||||||
1,226 | 1,929 | 888 | -2,306 | 1,686 | 1,042 | 1,164 | 1,161 | -451 | -1,478 |
Other | |||||||||
-45 | 0 | - | - | - | - | - | - | - | - |
Net cash provided by operating activities | |||||||||
34,433 | 28,901 | 18,996 | - | - | - | - | 17,284 | 17,484 | 17,374 |
Net cash provided by operating activities | |||||||||
- | - | - | 12,722 | 5,054 | 26,530 | 5,391 | - | - | - |
Cash Flows from Investing Activities: | |||||||||
Repayments and maturities of investment securities available for sale | |||||||||
5,491 | 5,995 | - | - | - | - | - | - | - | - |
Purchases of investment securities available for sale | |||||||||
- | - | - | 10,000 | 20,476 | 0 | 22,026 | 4,148 | 1,537 | 5,753 |
Redemptions of restricted stock | |||||||||
- | - | - | - | - | - | - | -1,342 | 525 | -54 |
Purchase of additional bank owned life insurance | |||||||||
- | - | - | - | - | - | - | 5,000 | - | - |
Repayments and maturities of investment securities available for sale | |||||||||
- | - | 7,129 | 0 | 0 | 3,974 | 1,508 | 1,000 | 500 | 3,790 |
Repayments and maturities of investment securities held to maturity | |||||||||
0 | 1,204 | 0 | 7,406 | 6,150 | 4,311 | 4,178 | 5,940 | 6,198 | 7,784 |
Net increase in loans | |||||||||
182,307 | 230,320 | - | - | - | - | - | - | - | - |
Net increase in loans | |||||||||
- | - | 161,590 | 138,996 | 55,541 | 68,084 | 37,808 | 23,378 | 6,173 | 57,062 |
Purchases of bank premises and equipment | |||||||||
594 | 138 | 2,148 | 875 | 352 | 118 | 113 | 225 | 209 | 1,766 |
Advances on OREO | |||||||||
- | - | - | 194 | 139 | 186 | 252 | 223 | 4,802 | 2,995 |
Donated OREO property | |||||||||
- | - | - | 31 | 0 | - | - | - | - | - |
Proceeds from sale of OREO, net | |||||||||
2,857 | 3,056 | 2,137 | 5,222 | 7,576 | 11,851 | 4,223 | 3,533 | 3,414 | 766 |
Redemptions (purchases) of restricted stock | |||||||||
-1,582 | 314 | - | - | - | - | - | - | - | - |
Redemption (purchase) of restricted stock | |||||||||
- | - | -1,514 | 131 | -1,637 | 466 | -1,395 | - | - | - |
Net cash used in investing activities | |||||||||
-176,135 | -219,889 | -155,986 | - | - | - | - | -21,159 | -3,134 | -55,182 |
Net cash used in investing activities | |||||||||
- | - | - | -84,289 | -64,419 | -47,786 | -51,685 | - | - | - |
Cash Flows from Financing Activities: | |||||||||
Cash dividends | |||||||||
- | - | - | - | - | - | 2 | 1 | 1 | 6 |
Payments of Ordinary Dividends, Preferred Stock and Preference Stock | |||||||||
6,490 | 5,412 | 4,385 | 3,234 | 2,661 | 1,575 | 816 | 815 | 815 | 813 |
Minority interest capital withdrawal, net | |||||||||
- | - | - | - | - | - | - | - | - | -125 |
Proceeds from exercise of stock options | |||||||||
48 | 43 | 132 | 190 | 2,697 | 114 | 290 | 35 | 0 | 32 |
Capital contribution (earnings distributions) from non-controlling interest | |||||||||
66 | - | - | 644 | 1,224 | 1,942 | 1,325 | 899 | -915 | - |
Capital contribution (earnings distributions) from non-controlling interest | |||||||||
- | 1,225 | - | - | - | - | - | - | - | - |
Net (decrease) increase in FHLBNY and short-term borrowings | |||||||||
30,000 | - | - | - | - | - | - | - | - | - |
Net (decrease) increase in FHLBNY and short-term borrowings | |||||||||
- | 10,000 | - | - | - | - | - | - | - | - |
Capital contribution (withdrawal) from non-controlling interest | |||||||||
- | - | -53 | - | - | - | - | - | - | - |
Net decrease in FHLBNY and short-term borrowings | |||||||||
- | - | 35,000 | -5,000 | 35,298 | -5,928 | - | - | - | - |
Redemption from sale of TARP warrants | |||||||||
- | - | - | - | - | - | 1,650 | 0 | - | - |
Proceeds from the issuance of Series B preferred stock, net | |||||||||
- | - | - | - | - | - | 18,539 | 0 | - | - |
Repurchase of Series A preferred stock | |||||||||
- | - | - | - | - | - | 14,340 | 0 | - | - |
Net decrease in other borrowed funds | |||||||||
- | - | - | - | - | - | 10,000 | 0 | - | - |
Net increase (decrease) in FHLBNY and short term borrowings | |||||||||
- | - | - | - | - | - | -34,832 | 30,159 | -9,848 | -11,454 |
Payments of Federal Home Loan Bank advances | |||||||||
- | - | - | - | - | - | - | - | - | 3,669 |
Net increase in noninterest-bearing deposits | |||||||||
-101,060 | 235,973 | 31,821 | 39,762 | 10,219 | 6,567 | 5,644 | -804 | 7,978 | 1,680 |
Net increase in interest-bearing deposits | |||||||||
256,406 | 81,517 | 45,868 | 83,722 | 7,058 | 14,597 | -16,083 | 3,156 | 22,155 | 82,729 |
Net cash provided by financing activities | |||||||||
178,838 | 303,346 | 108,383 | - | - | - | - | -29,487 | 38,250 | 91,282 |
Net increase in cash and cash equivalents | |||||||||
37,136 | 112,358 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
- | - | - | 114,858 | 50,556 | 11,833 | 15,089 | - | - | - |
Cash and Cash Equivalents, Period Increase (Decrease) | |||||||||
- | - | -28,607 | 43,291 | -8,809 | -9,423 | -31,205 | -33,362 | 52,600 | 53,474 |
Supplemental Disclosure of Cash Flow Information: | |||||||||
Interest paid | |||||||||
21,785 | 13,100 | 8,330 | 6,603 | 5,763 | 5,557 | 5,909 | 7,505 | 9,441 | -11,343 |
Income taxes paid | |||||||||
9,900 | 8,654 | 7,404 | 9,984 | 6,494 | 5,300 | 4,795 | 5,600 | 5,700 | -8,350 |
Non-cash Investing and Financing Items | |||||||||
Loans transferred to OREO | |||||||||
2,751 | 1,622 | 279 | - | - | - | - | - | - | - |
Establishment of lease liability and right-of-use asset | |||||||||
2,785 | - | - | - | - | - | - | - | - | - |
Real estate acquired in settlement of loans | |||||||||
- | - | - | 788 | 5,154 | 5,797 | 9,903 | 11,095 | 1,879 | -15,744 |